Skip to main content
. 2022 Sep 13;13:932252. doi: 10.3389/fimmu.2022.932252

Figure 6.

Figure 6

HLAII-presented sequences derived from anti-TNF compounds identified by HLAII immunopeptidomics. (A, B) Sequence coverage of identification within both light chain (LC) and heavy chain (HC) from antagonists detected in HLAII immunopeptidomes from antagonist-treated sets corresponding to INFL (blue) ADAL (green) and Fab’ (orange) (C) Length distribution of identified TNF antagonist-derived peptides from all donors.